Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Reorganization Advocates Seek Senate Boost For Disease-Oriented Structure

Executive Summary

Friends of Cancer Research proposes realignment of medical product functions by disease area without regard to modality; former commissioners give some support but new drugs Director Jenkins warns about unintended consequences that could negatively impact innovation and approvals.

Advertisement

Related Content

Does Imlygic Make The Case For FDA Oncology Center Of Excellence?
FDA Oncology Center Of Excellence Coming, Moonshot Or Not
Look Before Leaping To Reorganize FDA – Former Commissioner McClellan
Don't Rush To Reorganize FDA, McClellan Says
FDA Talent Hunt: Better To Recruit From Academia Than Industry?
FDA Talent Hunt: Better To Recruit From Academia Than Industry?
FDA Talent Hunt: Is Recruiting From Academia Better Than Industry?
Califf Supports Combo Products Pathway At Confirmation Hearing
FDA Reorganization Adds "Directorate" Layer, But Sharpens Agency's Focus
Oncology Drug Reviews To Be Restructured As Office Shifts Away From Divisions Organized Around Molecule Size

Topics

Advertisement
UsernamePublicRestriction

Register

PS057296

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel